MedPath

Study held to see effect of Nimba Amalaki tablet and Trunakadi oinment in management of Tinea.

Phase 2
Completed
Conditions
Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Registration Number
CTRI/2022/01/039508
Lead Sponsor
Mohini Bhagwan Niware
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

Patients with classical features of Dadru irrespective of chronicity.

Exclusion Criteria

1)Chronic illness and infection like TB skin cancer psoriasis Hansen disease generalized eczema malignant condition

2)person who is taking modern medicine for dadru

3)patients associated with other type of kushtha

4)Lesions with secondary infection

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To evaluate effect of Nimba Amalaki ghanavati and Trunakadi ointment on Dadru (tinea) <br/ ><br>To evaluate the reduction of elevated circular lesions by the application of Trunakadi ointment and administration of Nimba Amalaki ghanavati in management of dadruTimepoint: 14 days study with 2 follow ups (7th,14th day)
Secondary Outcome Measures
NameTimeMethod
To evaluate the reduction of elevated circular lesions by the application of Trunakadi ointment and administration of Nimba Amalaki ghanavati in management of dadruTimepoint: 14 days study
© Copyright 2025. All Rights Reserved by MedPath